Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 60.48
+2.50 (4.31%)
Jul 21, 2026, 3:05 PM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 24.39 billion as of July 21, 2026. Its market cap has decreased by -7.91% in one year.
Market Cap
24.39B
Enterprise Value
26.51B
Revenue
3.73B
Ranking
n/a
PE Ratio
55.11
Stock Price
60.48
ChartMarket Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 24.39B, an increase of 140.45%. That is a compound annual growth rate of 9.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 24.39B | 24.18% |
| Dec 31, 2025 | 19.64B | -12.96% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 28.48B |
| Shijiazhuang Yiling Pharmaceutical | 27.57B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 25.39B |
| Livzon Pharmaceutical Group | 24.79B |
| Hubei Jumpcan Pharmaceutical | 24.19B |
| Guangdong Zhongsheng Pharmaceutical | 24.08B |
| Zhejiang Huahai Pharmaceutical | 24.07B |
| Tasly Pharmaceutical Group | 22.98B |